Current role for induction chemotherapy in head and neck tumors;Stellenwert der induktionstherapie bei kopf-hals-tumoren

Laryngo- Rhino- Otologie

Volumn 87, Issue 4, 2008, Pages 237-243

  Dietz, Andreas ^a,f   Keilholz, U ^b   Werner, J ^c   Hagen, R ^d   Flentje, M ^d   Iro, H ^e  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Chemo selection; Head and neck tumor; Induction chemotherapy; Organ preservation

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; PACLITAXEL;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DYSPHAGIA; HEAD AND NECK CARCINOMA; HEAD AND NECK SURGERY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PUBLICATION; RADIATION DOSE; REVIEW; SCIENTIFIC LITERATURE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 42149177274     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995588     Document Type: Review

References (46)

1. Adelstein D, Saxton J, Lavertu P et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy aline in resectable stage III and IV squamous cell head and neck cancer: Preliminary results, chemoradiotherapy vs. radiotherapy. Head Neck 1997; 19: 567-575
2. Adelstein D, Li Y, Adams G et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21: 92-98
3. Bernier J, Schneider D. Cetuximab combined with radiotherapy: An alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck? Eur J Cancer 2007; 43: 35-45
4. Bonnano PC. Swallowing dysfunction after tracheotomy. Ann Surg 1971; 174: 29-33
5. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-578
6. Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot JC, Le Maitre A, Pajak TF, Poulsen MG, O'Sullivan B, Dobrowsky W, Hliniak A, Skladowski K, Hay JH, Pinto LH, fallai C, Fu KK, Sylvester R, Pignon JP. Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006; 368: 843-854
7. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 2081-2086
8. Calais G, Pointreau Y, Alfonsi M, Sire C, Tuchais C, Tortochaux J, Bourhis J, Guerrif S, Garaud P. 2006 ASCO Annual Meeting Proceedings Part I. Journal of Clinical Oncology 2006; Vol 24: No. 18 S (June 20 Supplement) 5506
9. Cox JD, Stetz J, Pajak T et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346
10. Denis F, Garaud P, Bardet E et al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced stage oropharynx carcinoma: Comparison of the LENT/SOMA, RTOG/EORTC, and the NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys 2003; 55: 93-98
11. Dietz A, Nollert J, Eckel H, Volling P, Schroder M, Staar S, Conradt C, Helmke B, Dollner R, Muller RP, Wannenmacher M, Weidauer H, Rudat V. Organerhalt beim fortgeschrittenen Larynx- bzw. Hypopharynxkarzinom durch primäre Radiochemotherapie. HNO 2002; 50: 146-154
12. Dietz A, Rudat V, Nollert J, Helbig M, Vanselow B, Weidauer H. Chronic laryngeal edema as a late reaction to radiochemotherapy. HNO 1998; 46: 731-738
13. Dietz A, Rudat V, Hoppe F, Pfreundner L, Flentje M. Induction chemotherapy with paclitaxel and cisplatin, followed by accelerated- hyperfractionated radiotherapy in patients with advanced laryngeal and hypopharyngeal cancer - the DeLOS (Deutsche Larynxorganerhaltung-Studiengruppe)- trial Procedings. Berlin: Deutscher Krebskongress, 2006
14. Dische S, Warburton M, Jones D et al. The recording of morbidity related to radiotherapy. Radiat Oncol 1989; 16: 103-108
15. Eibling DE, Gross RD. Subglottic air pressure: a key component of swallowing efficiency. Ann Otol Rhinol Laryngol 1996; 105: 253-258
16. Feldmann SA, Deal CW, Urquhart W. Disturbance of swallowing after tracheotomy. Lancet 1966; 1: 954-955
17. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098
18. Forastiere AA, Maor M, Weber RS et al. Long-term results of Intergroup RTOG 91-11: A phase III trial to preserve the larynx-Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. 2006 ASCO Annual Meeting Proceedings Part I. Journal of Clinical Oncology 2006; 24: 5517
19. Higgins DM, Maclean JC. Dysphagia in the patient with a tracheostomy: Six cases of inappropriate cuff deflation or removal. Heart and Lung 1997; 26: 215-220
20. Hillman RE, Walsh MJ, Wolf GT, Fisher SG, Hong WK. Functional outcomes following treatment for advanced laryngeal cancer. Part I - Voice preservation in advanced laryngeal cancer. Part II - Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol 1998; Suppl 172: 1-27
21. Hirt R, Lopez-Pousa A, Martinez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Marti JL, Lobo F, Pastor P, Valenti V, Belon J, Sanchez MA, Chaib C, Pallares C, Anton A, Cervantes A, Paz-Ares L, Cortes-Funes H. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 2005; 23: 8636-8645
22. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A, Robinson RA. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116: 1529-1542
23. Jeremic B, Shibamoto Y, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J, Vaskovic Z, Tadic L. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000; 18: 1458-1464
24. Knecht R, Baghi M, Hambek M, Tesch H, Gstottner W. Response rate and outcome of a novel induction chemotherapy regimen (TPF) in the first-line therapy of advanced head and neck carcinomas (SCCHN). Proc Am Soc Clin Oncol 2003; 22: 501 (Abstract 2017)
25. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996; 88: 890-899
26. Mohide EA, Archibald SD, Tew M, Young JE, Haines T. Postlaryngectomy quality-of-life dimensions identified by patients and health care professionals. Am J Surg 1992; 164: 619-622
27. Murray J. The laryngoscopy evaluation of swallowing or fees. In: Murray J (ed). Manual of Dysphagia Assessment in Adults. Singular Publishing Group, Inc, 1999: 153-190
28. Nash M. Swallowing problems in tracheotomized patient. Otolaryngol Clin North Am 1988; 21: 701-709
29. NCI/CTC Web site. http://ctep.info.nih.gov
30. Pfreundner L, Hoppe F, Willner J, Preisler V, Bratengeier K, Hagen R, Helms J, Flentje M. Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas - a possibility for organ preservation. Radiother Oncol 2003; 68: 163-170
31. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000; 355: 949-955
32. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio, Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI. TAX 324 Study Group. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007; 357: 1705-1715
33. Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, Stromboni-Luboinski M, Hill C. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 1998; 34: 224-228
34. Rosenthal DI, Lewin JS, Eisbruch A. Dysphagia after radiation therapy or chemoradiation for head and neck cancer. J Clin Oncol 2006; 24: 2636-2643
35. Rubin P, Constine S, Fajardo L et al. Overview of late effects of normal tissues (LENT-SOMA) scoring system. Int J Radiat Oncol Biol Phys 1995; 31: 1041-1042
36. Shaker R, Milbarth M, Ren J, Campbell B, Toohill R, Hogan W. Deglutitive Aspiration with tracheostomy: Effect of Tracheostomy on the duration of vocal chord closure. Gastroenterology 1995; 108: 154-159
37. Simon C, Plinkert PK. Transoral resection of locally advanced squamous cell carcinoma of the side wall of the oropharynx: multimodal treatment concepts in transition. Laryngoscope 2006; 116: 1529
38. Sticher H, Gratz C. Trachealkanülen-Management in der F. O. T. T. - Der Weg zurück zur Physiologie. In: Nusser-Müller-Busch R (Hrsg). Die Therapie des Facio-Oralen Trakts. Berlin, Heidelberg: Springer, 2004: 181-190
39. Terrell JE, Fisher SG, Wolf GT. Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg 1998; 124: 964-971
40. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-1690
41. Tolep K, Getch CL, Criner GJ. Swallowing dysfunction in patients receiving prolonged mechanical ventilation. Chest 1996; 109: 167-172
42. Trotti A, Bentzen SM. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol 2004; 22: 19-22
43. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL. EORTC 24971/TAX 323 Study Group. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007; 357: 1695-1704
44. Waters T, Logemann J, Pauloski B et al. Beyond efficacy and effectiveness: Conducting economic analyses during clinical trials. Dysphagia 2004; 19: 109-119
45. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: WHO Offset publication No. 48, 1979
46. Wyke BD. Myotactic reflexogenic systems in the larynx. Folia morphologica (Praha) 1973; 21: 113-117